<!doctype html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Ovulation</title>
<link rel="stylesheet" href="../../css/style.css">
<link rel="stylesheet" href="../../css/anatomy-modern.css">
</head>
<body>
<div class="container">
  <main id="content">
<h1><a id="_Toc392744129"></a><a id="_Toc469169042"></a><a id="_Toc218437394"></a>Ovulation</h1><h2>Definition</h2><p>The release of secondary oocyte with few cumulus oophorus cells along with first polar body encapsuled in zona pellucida from the surface of the ovary (Graafian follicle) and subsequent taking over by the fimbrial end of Fallopian tube fourteen days prior to next menstrual cycle </p><p>The oocyte enters the Fallopian tube aided by certain factors:</p><ul><li>The rupture of the follicle sets up currents in the peritoneal fluid, which carry the oocyte towards the ostium.</li><li>Movement of fimbriae- the beating fimbriae pull the oocyte towards the ostium of the Fallopian tube.</li></ul><p>On entering the Fallopian tube the oocyte proceeds towards the uterine cavity. </p><p>It is facilitated by:</p><ul><li>Beating of cilia of Fallopian tube towards the uterine cavity.</li><li>Contraction of the musculature of uterine tube.</li></ul><div class="clinical-box"><p>Normally the oocyte remains viable for 24 hrs after the ovulation.</p></div><p>If fertilization doesn't take place the oocyte is extruded along with the menstrual fluid.</p><h2>Ovulation Monitoring</h2><ul><li>Basal body temperature chart</li><li>Daily transvaginal ultrasonography</li><li>Serial measurement of LH</li><li>Estradiol E2</li><li>Urinary LH</li></ul><div class="warning-box"><p>Emerging: non-invasive saliva-based E2/LH (Adore Fertility 2025) and AI-wearables for continuous tracking.</p></div><h2>Clinical relevance </h2><p>Anovulation Diagnosis in PCOS: Absent LH surge or follicle rupture as detected by transvaginal ultrasonography</p><p>Timed Insemination/IVF: Monitoring (LH kits/USG) pinpoints 24-hour window; hCG trigger mimics surge for oocyte release, optimizing embryo transfer success.</p><p>Luteal Phase Defect: Short post-ovulation phase (&lt;10 days) → progesterone supplementation; BBT charts detect, preventing implantation failure.</p><p>Ovarian Hyperstimulation Syndrome (OHSS): Over-recruitment → multiple ovulations</p><p>Age-Related Decline: Immune-mediated rupture inefficiency (Northwestern 2025); AMH + antral count predicts; emerging Trim-Away tech targets meiotic errors for older oocytes.</p><p>Wearable Fertility Tracking: Real-time LH/E2 via apps empowers self-monitoring, reducing clinic visits for counseling.</p>
  </main>
</div>

<script src="../../js/interactive-features.js"></script>
</body>
</html>